Search

In Suk C. Bullock

Supervisory Patent Examiner (ID: 15423, Phone: (571)272-5954 , Office: P/1772 )

Most Active Art Unit
1764
Art Unit(s)
1797, 1106, 1772, 1764
Total Applications
717
Issued Applications
452
Pending Applications
77
Abandoned Applications
190

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4826827 [patent_doc_number] => 20080125371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)' [patent_app_type] => utility [patent_app_number] => 11/504217 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7201 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125371.pdf [firstpage_image] =>[orig_patent_app_number] => 11504217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/504217
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) Aug 14, 2006 Abandoned
Array ( [id] => 5189054 [patent_doc_number] => 20070167363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)' [patent_app_type] => utility [patent_app_number] => 11/504526 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7203 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167363.pdf [firstpage_image] =>[orig_patent_app_number] => 11504526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/504526
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) Aug 14, 2006 Abandoned
Array ( [id] => 5160411 [patent_doc_number] => 20070173455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)' [patent_app_type] => utility [patent_app_number] => 11/504224 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7199 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173455.pdf [firstpage_image] =>[orig_patent_app_number] => 11504224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/504224
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) Aug 13, 2006 Abandoned
Array ( [id] => 5688278 [patent_doc_number] => 20060286593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Transforming Growth Factor Alpha HI' [patent_app_type] => utility [patent_app_number] => 11/464386 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13723 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286593.pdf [firstpage_image] =>[orig_patent_app_number] => 11464386 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/464386
Transforming Growth Factor Alpha HI Aug 13, 2006 Abandoned
Array ( [id] => 5446014 [patent_doc_number] => 20090047240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'CHAPERONIN 10-INDUCED IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 11/995524 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 25316 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047240.pdf [firstpage_image] =>[orig_patent_app_number] => 11995524 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995524
Chaperonin 10-induced immunomodulation Jul 10, 2006 Issued
Array ( [id] => 62607 [patent_doc_number] => 07763437 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-07-27 [patent_title] => 'Methods for identifying compounds that regulate β-Arrestin signaling complexes' [patent_app_type] => utility [patent_app_number] => 11/482277 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2525 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763437.pdf [firstpage_image] =>[orig_patent_app_number] => 11482277 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/482277
Methods for identifying compounds that regulate β-Arrestin signaling complexes Jul 6, 2006 Issued
Array ( [id] => 5204956 [patent_doc_number] => 20070026437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Novel BMP products' [patent_app_type] => utility [patent_app_number] => 11/472281 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14433 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026437.pdf [firstpage_image] =>[orig_patent_app_number] => 11472281 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/472281
Novel BMP products Jun 21, 2006 Abandoned
Array ( [id] => 5888893 [patent_doc_number] => 20060275868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Fusion proteins comprising tumor necrosis factor receptor' [patent_app_type] => utility [patent_app_number] => 11/451450 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20973 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275868.pdf [firstpage_image] =>[orig_patent_app_number] => 11451450 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/451450
Fusion proteins comprising tumor necrosis factor receptor Jun 12, 2006 Abandoned
Array ( [id] => 5760660 [patent_doc_number] => 20060211605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Mucosal repair by TFF dimer peptides' [patent_app_type] => utility [patent_app_number] => 11/439690 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7887 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211605.pdf [firstpage_image] =>[orig_patent_app_number] => 11439690 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/439690
Mucosal repair by TFF dimer peptides May 22, 2006 Abandoned
Array ( [id] => 103088 [patent_doc_number] => 07723473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Peptide antagonists of TGF-beta family members and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/432125 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12590 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723473.pdf [firstpage_image] =>[orig_patent_app_number] => 11432125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/432125
Peptide antagonists of TGF-beta family members and therapeutic uses thereof May 10, 2006 Issued
Array ( [id] => 5398275 [patent_doc_number] => 20090318338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'METHODS FOR MODULATING BONE FORMATION AND MINERALIZATION BY MODULATING KRC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/918503 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43940 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318338.pdf [firstpage_image] =>[orig_patent_app_number] => 11918503 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/918503
Methods for modulating bone formation and mineralization by modulating KRC activity Apr 13, 2006 Issued
Array ( [id] => 5667041 [patent_doc_number] => 20060172391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'BMP-11 compositions' [patent_app_type] => utility [patent_app_number] => 11/401228 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12868 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172391.pdf [firstpage_image] =>[orig_patent_app_number] => 11401228 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/401228
BMP-11 compositions Apr 10, 2006 Abandoned
Array ( [id] => 5586261 [patent_doc_number] => 20090105463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Compositions of and Methods of Using Oversulfated Glycosaminoglycans' [patent_app_type] => utility [patent_app_number] => 11/887559 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 39340 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105463.pdf [firstpage_image] =>[orig_patent_app_number] => 11887559 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887559
Compositions of and Methods of Using Oversulfated Glycosaminoglycans Mar 28, 2006 Abandoned
Array ( [id] => 5546600 [patent_doc_number] => 20090156477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Compositions and Methods for Regulating Inflammatory Responses' [patent_app_type] => utility [patent_app_number] => 11/887561 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27578 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156477.pdf [firstpage_image] =>[orig_patent_app_number] => 11887561 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887561
Compositions and Methods for Regulating Inflammatory Responses Mar 28, 2006 Abandoned
Array ( [id] => 5322879 [patent_doc_number] => 20090060869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE' [patent_app_type] => utility [patent_app_number] => 11/908600 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9903 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060869.pdf [firstpage_image] =>[orig_patent_app_number] => 11908600 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908600
EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE Mar 27, 2006 Abandoned
Array ( [id] => 5700625 [patent_doc_number] => 20060217310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Fibroblast growth factor 1 (FGF-1) used for skin care' [patent_app_type] => utility [patent_app_number] => 11/387051 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5721 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217310.pdf [firstpage_image] =>[orig_patent_app_number] => 11387051 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/387051
Fibroblast growth factor 1 (FGF-1) used for skin care Mar 22, 2006 Abandoned
Array ( [id] => 5324202 [patent_doc_number] => 20090062192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Dimeric Peptide Agonists of the Glp-1 Receptor' [patent_app_type] => utility [patent_app_number] => 11/908835 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14798 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062192.pdf [firstpage_image] =>[orig_patent_app_number] => 11908835 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908835
Dimeric Peptide Agonists of the Glp-1 Receptor Mar 19, 2006 Abandoned
Array ( [id] => 5259109 [patent_doc_number] => 20070212741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Diagnostic markers for sub-acute ruminal acidosis' [patent_app_type] => utility [patent_app_number] => 11/372170 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11985 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212741.pdf [firstpage_image] =>[orig_patent_app_number] => 11372170 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372170
Diagnostic markers for sub-acute ruminal acidosis Mar 9, 2006 Abandoned
Array ( [id] => 5632580 [patent_doc_number] => 20060149050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Isolation and method of using tissue growth-inducing Frzb' [patent_app_type] => utility [patent_app_number] => 11/369089 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14615 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20060149050.pdf [firstpage_image] =>[orig_patent_app_number] => 11369089 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369089
Isolation and method of using tissue growth-inducing Frzb Mar 5, 2006 Abandoned
Array ( [id] => 32490 [patent_doc_number] => 07785579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Modified tumor necrosis factor' [patent_app_type] => utility [patent_app_number] => 11/363863 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785579.pdf [firstpage_image] =>[orig_patent_app_number] => 11363863 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/363863
Modified tumor necrosis factor Feb 26, 2006 Issued
Menu